ÂÜÀòÂÒÂ×

Hongxiu Ning has held various scientific roles at companies such as CERo Therapeutics, Allogene Therapeutics, Pfizer, and University of California, San Francisco. Currently working at UCSF Medical Center, with a background in oncology and cancer biology, Hongxiu's research focuses on activating endogenous stem cells using non-invasive methods and exploring related mechanisms. Prior to this, Hongxiu was involved in mesenchymal stem cell research during postdoctoral training at UCSF.